Prognostic factors and radiotherapy resulst in the patients with Tis and T1-glottic cancer

被引:0
|
作者
Demiroz, Candan
Ozturk, Gul A.
Kurt, Meral
Cetintas, Sibel K.
Coskun, Hakan
Ozkan, Lutfi
机构
[1] Uludag Univ, Fac Med, Dept Radiat Oncol, Bursa, Turkey
[2] Uludag Univ, Fac Med, Dept Head & Neck Surg, Bursa, Turkey
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:186 / 186
页数:1
相关论文
共 50 条
  • [21] T1-2 glottic cancer treated with radiotherapy and/or surgery
    Shelan, Mohamed
    Anschuetz, Lukas
    Schubert, Adrian D.
    Bojaxhiu, Beat
    Dal Pra, Alan
    Behrensmeier, Frank
    Aebersold, Daniel M.
    Giger, Roland
    Elicin, Olgun
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (12) : 995 - 1004
  • [22] High daily fraction dose external radiotherapy for T1 glottic carcinoma: Treatment results and prognostic factors
    Gultekin, Melis
    Ozyar, Enis
    Cengiz, Mustafa
    Ozyigit, Gokhan
    Hayran, Mutlu
    Hosal, Sefik
    Akyol, Fadil
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (07): : 1009 - 1014
  • [23] Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy
    Al-Mamgani, Abrahim
    van Rooij, Peter H.
    Mehilal, Robert
    Verduijn, Gerda M.
    Tans, Lisa
    Kwa, Stefan L. S.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (01) : 125 - 132
  • [24] Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy
    Abrahim Al-Mamgani
    Peter H. van Rooij
    Robert Mehilal
    Gerda M. Verduijn
    Lisa Tans
    Stefan L. S. Kwa
    European Archives of Oto-Rhino-Laryngology, 2014, 271 : 125 - 132
  • [25] Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patients
    Sanguineti, Giuseppe
    Pellini, Raul
    Vidiri, Antonello
    Marzi, Simona
    D'Urso, Pasqualina
    Terrenato, Irene
    Farneti, Alessia
    Fuga, Valentina
    Ungania, Sara
    Landoni, Valeria
    TUMORI JOURNAL, 2021, 107 (06): : 514 - 524
  • [26] Hypofractionated vs standard radical radiotherapy in early (T1-T2) glottic cancer patients.
    Gonzalez Ruiz, M. A.
    Cabrera Rodriguez, J. J.
    Ruiz Herrero, A.
    Cruz Munoz, M. C.
    Simon Silva, P.
    Quiros Rivero, J.
    Munoz Garcia, J. L.
    Rios Kavadoy, Y.
    Ropero Carmona, M. F.
    Garcia Urra, F.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S584 - S584
  • [27] T1-2 glottic cancer treated with radiotherapy and/or surgery Comment
    Bohr, Christopher
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (04) : 352 - 353
  • [28] Voice and Quality-of-Life Outcomes of Diode Laser for Tis-T1a Glottic Cancer
    Sencan, Ziya
    Comert, Ela
    Tuncel, Umit
    Kilic, Caner
    ENT-EAR NOSE & THROAT JOURNAL, 2020, 99 (04) : 229 - 234
  • [29] CO2 LASER THERAPY IN Tis AND T1 GLOTTIC CANCER: INDICATIONS AND RESULTS
    Rucci, Lucio
    Romagnoli, Paolo
    Scala, Jacopo
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (03): : 392 - 398
  • [30] RADIOTHERAPY IN T1 GLOTTIC CANCER: HAVE WE REACHED A CEILING?
    Geropantas, K.
    Loo, S.
    Martin, C.
    Roques, T.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S332 - S332